An association has been reported between BP and DPP-4 inhibitors. We
report three cases of DPP-4 inhibitor-associated BP, with an unfavorable
course in 2 patients despite discontinuation of these drugs. Therefore,
clinicians should pay close attention to the clinical course of DPP-4
inhibitor-associated BP, even after withdrawal of these drugs.